ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1270

Trend of Survival of a Cohort of Patients with Systemic Lupus Erythematosus over 25 Years

Chi Chiu Mok1, Ling Yin Ho1, Kar Li Chan2, Sau Mei Tse2 and Chi Hung To3, 1Tuen Mun Hospital, Hong Kong, China (People's Republic), 2Tuen Mun Hospital, Hong Kong, Hong Kong, 3Pok Oi Hospital, Hong Kong, Hong Kong

Meeting: ACR Convergence 2020

Keywords: Mortality, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Comorbidities

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Background: Few studies of systemic lupus erythematosus (SLE) have a follow-up duration long enough to evaluate the time trend of survival, particularly in Asian countries.

Objectives: To revisit the trend of survival of SLE in a cohort of southern Chinese patients over 25 years.

Methods: Patients who fulfilled the 1997 ACR criteria for SLE and were followed in our hospital since 1995 were included.  Patients were stratified into 2 groups according to the year of diagnosis: (1) 1995-2004; and (2) 2005-2018.  Survival of patients was studied by Kaplan Miere’s analysis. For those who died or lost to follow-up, data were censored at their last clinic / hospital visits.  Organ damage was assessed by the Systemic Lupus International Collaborating Clinics (SLICC) damage index (SDI) and causes of death in the first 10 years of SLE onset were compared between the two groups.  Cox regression was used to study factors associated with survival. 

Results:  A total of 1098 SLE patients were registered in our database.  After excluding 157 patients diagnosed outside the time period of 1995-2018, 941 patients were studied (92% women).  All were ethnic Chinese.  The mean age of SLE onset was 35.1±14.4 years and the mean follow-up duration by the same groups of physicians was 13.1±6.6 years.  Seventy-seven patients were lost to follow up.  Groups 1 and 2 consisted of 364 and 577 patients, respectively.    The mean SDI score at 10 years of disease onset was significantly higher in group 1 than group 2 patients (1.01±1.43 vs 0.57±0.94; p< 0.01), particularly in the neuropsychiatric, musculoskeletal and gonadal domains.  The proportion of patients with organ damage in these 3 systems was also significantly higher in this group of patients.  Within 10 years of SLE onset, 32 (8.8%) patients in group 1 and 25 (4.3%) patients in group 2 died (p=0.005).  The 5- and 10-year cumulative survival rates were 93.6% and 91.0% in group 1; and 96.5% and 94.2% in group 2 patients, respectively (log rank test p=0.048).  Infection accounted for more than half of the deaths in both groups.  More group 1 than group 2 patients died of vascular events but the difference was not statistically significant. Univariate Cox regression analysis showed that age of onset, male sex and SDI score at 10 years were associated with survival. Group 2 patients showed a better survival than group 1 but statistical significance was borderline (HR 0.61[0.38-1.001]; p=0.05).  Multivariate analysis revealed only the age of onset (1.06 [1.04-1.08] per year; p< 0.001) and SDI at 10 years (1.65 [1.47-1.85] per point; p< 0.001) were significantly associated with survival.  The period in which SLE was diagnosed was not a significant factor determining survival (HR 0.68[0.41-1.14]; p=0.14).

Conclusion: The survival of our Chinese SLE patients has improved significantly from 1995-2004 to 2005-2018, which is contributed by lower organ damage accrual.


Disclosure: C. Mok, None; L. Ho, None; K. Chan, None; S. Tse, None; C. To, None.

To cite this abstract in AMA style:

Mok C, Ho L, Chan K, Tse S, To C. Trend of Survival of a Cohort of Patients with Systemic Lupus Erythematosus over 25 Years [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/trend-of-survival-of-a-cohort-of-patients-with-systemic-lupus-erythematosus-over-25-years/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trend-of-survival-of-a-cohort-of-patients-with-systemic-lupus-erythematosus-over-25-years/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology